Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_assertion type Assertion NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_head.
- NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_assertion description "[These IGF-I variants may potentially be useful for treating disease conditions associated with up-regulated IGFBP-1 levels, such as chronic or acute renal and hepatic failure or uncontrolled diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_provenance.
- NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_assertion evidence source_evidence_literature NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_provenance.
- NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_assertion SIO_000772 11145579 NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_provenance.
- NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_assertion wasDerivedFrom befree-2016 NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_provenance.
- NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_assertion wasGeneratedBy ECO_0000203 NP304579.RATQmzl2RWJupwFqW8cHsUI8BqKYCKdWBwbksAnNxBcmI130_provenance.